Brandywine Global Investment Management’s Abeona Therapeutics ABEO Stock Holding History

Brandywine Global Investment Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,448	Closed	-$197K	–	793
2019 Q4	$197K	Buy	2,448 +436	+22%	+$30.8K	﹤0.01%	645
2019 Q3	$114K	Hold	2,012	–	–	﹤0.01%	678
2019 Q2	$241K	Buy	2,012 +7	+0.3%	+$1.17K	﹤0.01%	616
2019 Q1	$369K	Sell	2,005 -243	-11%	-$43.4K	﹤0.01%	584
2018 Q4	$402K	Sell	2,248 -51	-2%	-$11.1K	﹤0.01%	573
2018 Q3	$736K	Buy	2,299 +4	+0.2%	+$1.42K	﹤0.01%	578
2018 Q2	$918K	Sell	2,295 -61	-3%	-$26.7K	0.01%	589
2018 Q1	$846K	Sell	2,356 -868	-27%	-$322K	0.01%	588
2017 Q4	$1.28M	Sell	3,224 -354	-10%	-$146K	0.01%	571
2017 Q3	$1.53M	Buy	+3,578	New	+$962K	0.01%	567

Other funds holding ABEO

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Brandywine Global Investment Management's ABEO Position: Q1 2020 in Review

Brandywine Global Investment Management sold out of Abeona Therapeutics (ABEO) in Q1 2020, closing a stake of 2,448 shares — an estimated $197K sold.

Brandywine Global Investment Management first reported a position in ABEO in Q3 2017 and held it in 10 quarters. The position peaked at $1.53M in Q3 2017. 80 funds tracked by Wall St. Rank hold ABEO as of Q1 2020.

Brandywine Global Investment Management reported no remaining Abeona Therapeutics position as of Q1 2020 after selling out during the quarter.
Brandywine Global Investment Management sold 2,448 Abeona Therapeutics shares in Q1 2020, an estimated $197K.
Brandywine Global Investment Management first reported a position in Abeona Therapeutics in Q3 2017 and held it in 10 quarters.
Brandywine Global Investment Management's Abeona Therapeutics position peaked at $1.53M in Q3 2017.
80 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2020.

Based on Brandywine Global Investment Management's 13F filing for Q1 2020, filed 15 May 2020.